Point-of-care Ultrasound for Acute Kidney Injury

• Sponsor: Mehmet Ali Aslaner (Other)
• Overall Status: Completed
• CT.gov ID: NCT04470661
• Collaborator: (none)
• Enrollment: 130
• Location: 1
• Actual Duration (Months): 11.9
• Patients Per Site Per Month: 10.9

Study Details

Study Description

Brief Summary

It is aimed to determine prerenal, renal and postrenal diagnoses of patients with acute kidney injury with POCUS performed in the emergency department. Patients who presented to the emergency department and who have acute kidney injury (AKI) according to the KDIGO criteria will be evaluated and patients diagnosed with AKI will be included in the study. The diagnostic accuracy of POCUS with the AKI etiologies of the patients will be evaluated.

Condition or Disease	Intervention/Treatment	Phase
Acute Kidney Injury	Diagnostic Test: Ultrasonography

Study Design

• Study Type: Observational
• Actual Enrollment: 130 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Diagnostic Accuracy of Point-of-Care Ultrasound in the Etiology of Acute Kidney Injury
• Actual Study Start Date: Aug 1, 2020
• Actual Primary Completion Date: Jul 30, 2021
• Actual Study Completion Date: Jul 30, 2021

Outcome Measures

Primary Outcome Measures

1. The diagnostic accuracy of POCUS in the patients with AKI [One year]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• AKI diagnosis according to KDIGO criteria

Exclusion Criteria:

• Patients with end stage renal failure,

• Failure to perform POCUS in the first two hours of presentation of patient,

• Those with renal malignancy,

• Pregnant women,

• Renal transplantation patients,

• Patients with a single kidney,

• Those with polycystic kidney disease,

• Patients with nephrostomy,

• Patients who are referred from another center,

• Unable to perform adequate imaging,

• Patients who do not give consent for the study will be excluded.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Gazi University Facaulty of Medicine	Ankara		Turkey

Sponsors and Collaborators

• Mehmet Ali Aslaner

Investigators

• Principal Investigator: Mehmet Aslaner, MD, Gazi University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Mehmet Ali Aslaner, Assoc. Prof., Gazi University
• ClinicalTrials.gov Identifier: NCT04470661
• Other Study ID Numbers: GaziU-2
• First Posted: Jul 14, 2020
• Last Update Posted: Mar 16, 2022
• Last Verified: Mar 1, 2022

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Acute Kidney Injury; Wounds and Injuries

Study Results

No Results Posted as of Mar 16, 2022